Cargando…
Daratumumab for immune thrombotic thrombocytopenic purpura
Immune thrombotic thrombocytopenic purpura (iTTP) is a life-threatening thrombotic microangiopathy. It is caused by a severe ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 motifs, 13) deficiency due to circulating autoantibodies, and is associated with significant morbidity a...
Autores principales: | van den Berg, Jana, Kremer Hovinga, Johanna A., Pfleger, Claudia, Hegemann, Inga, Stehle, Gregor, Holbro, Andreas, Studt, Jan-Dirk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945322/ https://www.ncbi.nlm.nih.gov/pubmed/34551063 http://dx.doi.org/10.1182/bloodadvances.2021005124 |
Ejemplares similares
-
Hypertension in patients with hereditary thrombotic thrombocytopenic purpura
por: Borogovac, Azra, et al.
Publicado: (2020) -
Long-term Kidney Outcomes in Patients With Acquired Thrombotic Thrombocytopenic Purpura
por: Little, Dustin J., et al.
Publicado: (2017) -
Thrombotic thrombocytopenic purpura
por: Knöbl, Paul
Publicado: (2018) -
Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
por: Agosti, Pasquale, et al.
Publicado: (2023) -
Thrombotic Thrombocytopenic Purpura and Gemcitabine
por: Kasi, Pashtoon Murtaza
Publicado: (2011)